uSWKAMEOOnZFlNc
A financial advisor finpecia online Lilly earlier this year asked U.S. and European regulators to approve two new diabetes treatments. One, a once-weekly injectable drug called dulaglutide that is a so-called GLP-1 agonist, would compete with similar drugs sold by Novo Nordisk and Bristol-Myers Squibb. Another, called empaglifozin, is a member of an emerging new family of oral treatments called SGLT2 inhibitors that remove excess blood sugar through the urine.